Steven D Lovrich from 1626 Keller Ct, Onalaska, WI 54650, age 59, Phone: (608)7837277

Compositions And Methods Using The Borreliacidal Epitope(S) Of Borrelia Burgdorferi Outer Surface Protein C (Ospc) For The Diagnosis And Prevention Of Lyme Disease
view source
US Patent:

6464985, Oct 15, 2002
Filed:

Aug 30, 2000
Appl. No.:

09/651419
Inventors:

Steven M. Callister - La Crosse WI
Steven D. Lovrich - La Crosse WI
Ronald F. Schell - Dade WI
Dean A. Jobe - La Crosse WI
Assignee:

Gundersen Lutheran Medical Foundation, Inc. - La Crosse WI
International Classification:

A61K 3902
US Classification:

4242341, 4241901, 4241841, 530350, 530300, 530825, 514 2, 514825
Abstract:

An OspC Dra fragment fusion peptide isolated from is described herein for the prevention, treatment and early diagnosis of Lyme disease in humans and other animals. This invention also relates to a screening method detecting anti-Osp borreliacidal antibody activity, and antibodies reacting with a protein fragment encoded by a DraI-SmaI DNA fragment of OspC.

Compositions And Methods Using The Borreliacidal Epitope(S) Of Borrelia Burgdorferi Outer Surface Protein C (Ospc) For The Diagnosis And Prevention Of Lyme Disease
view source
US Patent:

62106767, Apr 3, 2001
Filed:

Jul 30, 1999
Appl. No.:

9/364083
Inventors:

Steven M. Callister - La Crosse WI
Steven D. Lovrich - La Crosse WI
Ronald F. Schell - Dade WI
Dean A. Jobe - La Crosse WI
Assignee:

Gundersen Lutheran Medical Foundation - La Crosse WI
International Classification:

A61K 3902
A61K 4500
A61K 3900
A61K 3800
C07K 100
US Classification:

4241901
Abstract:

An OspC Dra fragment fusion peptide isolated from Borrelia burgdorferi is described herein for the prevention, treatment and early diagnosis of Lyme disease in humans and other animals. This invention also relates to a screening method detecting anti-Osp borreliacidal antibody activity, and antibodies reacting with a protein fragment encoded by a DraI-SmaI DNA fragment of OspC.

Steven D Lovrich